Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography.

Papadopoulos N, Vasileiadi S, Papavdi M, Sveroni E, Antonakaki P, Dellaporta E, Koutli E, Michalea S, Manolakopoulos S, Koskinas J, Deutsch M.

Ann Gastroenterol. 2019 Sep-Oct;32(5):498-503. doi: 10.20524/aog.2019.0406. Epub 2019 Jul 22.

2.

Emerging Role of l-Dopa Decarboxylase in Flaviviridae Virus Infections.

Frakolaki E, Kalliampakou KI, Kaimou P, Moraiti M, Kolaitis N, Boleti H, Koskinas J, Vassilacopoulou D, Vassilaki N.

Cells. 2019 Aug 5;8(8). pii: E837. doi: 10.3390/cells8080837.

3.

Intergenotypic 2k/1b hepatitis C virus recombinants in the East Macedonia and Thrace region of Greece.

Kassela K, Karakasiliotis I, Kokkiou E, Souvalidou F, Mimidis P, Veletza S, Panopoulou M, Koskinas J, Mimidis K, Mavromara P.

Ann Gastroenterol. 2019 Jan-Feb;32(1):88-92. doi: 10.20524/aog.2018.0322. Epub 2018 Nov 2.

4.

Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis.

Dalekos GN, Koskinas J, Papatheodoridis GV.

Ann Gastroenterol. 2019 Jan-Feb;32(1):1-23. doi: 10.20524/aog.2018.0330. Epub 2018 Nov 29.

5.

Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issues.

Tampaki M, Savvanis S, Koskinas J.

Ann Gastroenterol. 2018 Nov-Dec;31(6):670-679. doi: 10.20524/aog.2018.0306. Epub 2018 Sep 14. Review.

6.

Transient Elastography (TE) is a Useful Tool for Assessing the Response of Liver Iron Chelation in Sickle Cell Disease Patients.

Delicou S, Maragkos K, Tambaki M, Kountouras D, Koskinas J.

Mediterr J Hematol Infect Dis. 2018 Sep 1;10(1):e2018049. doi: 10.4084/MJHID.2018.049. eCollection 2018.

7.

Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues.

Papadopoulos N, Papavdi M, Pavlidou A, Konstantinou D, Kranidioti H, Kontos G, Koskinas J, Papatheodoridis GV, Manolakopoulos S, Deutsch M.

Ann Gastroenterol. 2018 May-Jun;31(3):365-370. doi: 10.20524/aog.2018.0255. Epub 2018 Mar 28.

8.

Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein.

Deutsch M, Manolakopoulos S, Andreadis I, Giannaris M, Kontos G, Kranidioti H, Pirounaki M, Koskinas J.

Ann Gastroenterol. 2018 Jan-Feb;31(1):77-83. doi: 10.20524/aog.2017.0207. Epub 2017 Oct 26.

9.

High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis.

Kassela K, Karakasiliotis I, Charpantidis S, Koskinas J, Mylopoulou T, Mimidis K, Sarrazin C, Grammatikos G, Mavromara P.

J Gen Virol. 2017 Jul;98(7):1713-1719. doi: 10.1099/jgv.0.000851. Epub 2017 Jul 15.

PMID:
28708052
10.

Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.

Sinakos E, Kountouras D, Koskinas J, Zachou K, Karatapanis S, Triantos C, Vassiliadis T, Goulis I, Kourakli A, Vlachaki E, Toli B, Tampaki M, Arvaniti P, Tsiaoussis G, Bellou A, Kattamis A, Maragkos K, Petropoulou F, Dalekos GN, Akriviadis E, Papatheodoridis GV.

Br J Haematol. 2017 Jul;178(1):130-136. doi: 10.1111/bjh.14640. Epub 2017 Apr 25.

PMID:
28439915
11.

Antiplatelets and Antithrombotics in Patients with Liver Insufficiency: From Pathophysiology to Clinical Practice.

Deutsch M, Koskinas J.

Curr Pharm Des. 2017;23(9):1346-1353. doi: 10.2174/1381612822666161205113629. Review.

PMID:
27917713
12.

Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.

Papadopoulos N, Deutsch M, Manolakopoulos S, Bitsi C, Michalakeas H, Poulakidas H, Tsironi E, Giannouli S, Papatheodoridis GV, Koskinas J, Pectasides D.

Eur J Gastroenterol Hepatol. 2017 Jan;29(1):56-60.

PMID:
27669175
13.

Erratum to: Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma.

Malagari K, Kiakidis T, Pomoni M, Moschouris H, Emmanouil E, Spiridopoulos T, Sotirchos V, Tandeles S, Koundouras D, Kelekis A, Filippiadis D, Charokopakis A, Bouma E, Chatziioannou A, Dourakis S, Koskinas J, Karampelas T, Tamvakopoulos K, Kelekis N, Kelekis D.

Cardiovasc Intervent Radiol. 2016 Oct;39(10):1537. No abstract available.

PMID:
27468837
14.

Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma.

Malagari K, Kiakidis T, Pomoni M, Moschouris H, Emmanouil E, Spiridopoulos T, Sotirchos V, Tandeles S, Koundouras D, Kelekis A, Filippiadis D, Charokopakis A, Bouma E, Chatziioannou A, Dourakis S, Koskinas J, Karampelas T, Tamvakopoulos K, Kelekis N, Kelekis D.

Cardiovasc Intervent Radiol. 2016 Oct;39(10):1379-91. doi: 10.1007/s00270-016-1382-6. Epub 2016 Jul 8. Erratum in: Cardiovasc Intervent Radiol. 2016 Oct;39(10):1537.

PMID:
27393274
15.

Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.

Foka P, Dimitriadis A, Karamichali E, Kyratzopoulou E, Giannimaras D, Koskinas J, Varaklioti A, Mamalaki A, Georgopoulou U.

Virulence. 2016 Aug 17;7(6):679-90. doi: 10.1080/21505594.2016.1175700. Epub 2016 Apr 8.

16.

Common ABCB1 polymorphisms in Greek patients with chronic hepatitis C infection: A comparison with hyperlipidemic patients and the general population.

Gbandi E, Goulas A, Sevastianos V, Hadziyannis S, Panderi A, Koskinas J, Papatheodoridis G, Vasiliadis T, Agapakis D, Protopapas A, Ioannidou P, Zacharakis G, Sinakos E, Koutsounas S, Germanidis G.

Pharmacol Rep. 2016 Apr;68(2):476-82. doi: 10.1016/j.pharep.2015.10.009. Epub 2015 Nov 6.

PMID:
26922556
17.

Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience.

Manolakopoulos S, Kranidioti H, Goulis J, Vlachogiannakos J, Elefsiniotis J, Kouroumalis EA, Koskinas J, Kontos G, Evangelidou E, Doumba P, Sinakos E, Vafiadou Ι, Koulentaki M, Papatheodoridis G, Akriviadis E.

Ann Gastroenterol. 2015 Oct-Dec;28(4):481-6.

18.

Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights.

Tampaki M, Doumba PP, Deutsch M, Koskinas J.

World J Hepatol. 2015 Jul 18;7(14):1834-42. doi: 10.4254/wjh.v7.i14.1834. Review.

19.

Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma.

Fatourou E, Koskinas J, Karandrea D, Palaiologou M, Syminelaki T, Karanikolas M, Felekouras E, Antoniou E, Manesis EK, Delladetsima J, Tiniakos D.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1094-102. doi: 10.1097/MEG.0000000000000398.

PMID:
26011233
20.

Liver innervation and hepatic function: new insights.

Kandilis AN, Papadopoulou IP, Koskinas J, Sotiropoulos G, Tiniakos DG.

J Surg Res. 2015 Apr;194(2):511-9. doi: 10.1016/j.jss.2014.12.006. Epub 2014 Dec 8. Review.

PMID:
25555404

Supplemental Content

Loading ...
Support Center